• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>GlaxoSmithKline PLC

GlaxoSmithKline PLC

GlaxoSmithKline PLC ADR GSK 3 Star

Last Price$47.59Day Change (%)2.18%
Open Price$47.43Day Change ($)1.02
Day Range47.31–47.7552-Week Range41.25–56.48

As of Mon 4/27/2015 12:34:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Research and Markets: Global Dermatitis Pipeline Review 2015

    Research and Markets: Global Dermatitis Pipeline Review 2015

  2. Novartis Begins to See Benefits of Overhaul -- 2nd Update

    Novartis Begins to See Benefits of Overhaul -- 2nd Update

  3. Novartis Begins to See Benefits of Overhaul -- Update

    Novartis Begins to See Benefits of Overhaul -- Update

  4. UPDATE: U.S. Firms Urge China to Improve Conditions

    UPDATE: U.S. Firms Urge China to Improve Conditions

  5. U.S. Firms Want China to Improve Business Conditions

    U.S. Firms Want China to Improve Business Conditions

  6. Research and Markets: Kidney Cancer Drugs (Afinitor, Avastin, Inlyta, Nexavar, Proleukin, Sutent, Torisel, Votrient) Market - Global Industry Analysis 2014-2020

    Research and Markets: Kidney Cancer Drugs (Afinitor, Avastin, Inlyta, Nexavar, Proleukin, Sutent, Torisel, Votrient) Market - Global Industry Analysis 2014-2020

  7. Squabbles Over Testing Methods Hamper Search for Ebola Vaccine

    Squabbles Over Testing Methods Hamper Search for Ebola Vaccine

  8. Bayer's CEO Injects a Dose of U.S. Risk-Taking

    Bayer's CEO Injects a Dose of U.S. Risk-Taking

  9. At Bayer, A Dose Of US Risk-Taking

    At Bayer, A Dose Of US Risk-Taking

  10. Research and Markets: Non-Rhabdomyosarcoma Global Clinical Trials Review, H1, 2015

    Research and Markets: Non-Rhabdomyosarcoma Global Clinical Trials Review, H1, 2015

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.